Speech-Language Pathologists in Woodward, OK Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Mrs. Amanda Ann Hensley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1610 2nd St, Woodward, OK 73801 Phone: 580-256-6063 |
Becky Castor, MSCCC-SUP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Hillcrest Dr, Woodward, OK 73801 Phone: 580-256-6100 Fax: 580-256-6101 |
Susan Sell, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1023 10th St, Woodward, OK 73801 Phone: 580-256-6063 |
Ms. Kathryn Bethany Shore, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1023 10th St, Woodward, OK 73801 Phone: 580-256-6063 |
Mrs. Natalie Rae Laverty, M.A., C.C.C. - S.L.P Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 21st St, Woodward, OK 73801 Phone: 580-256-9551 |
News Archive
Australia to provide Gardasil at no cost to girls and women ages 12 to 26
Australian Prime Minister John Howard on Wednesday announced that the government will provide about $342 million for a program that will offer Merck's human papillomavirus vaccine Gardasil at no cost to girls and women ages 12 to 26 living in the country, Bloomberg reports.
Transcranial MR-guided focused ultrasound for brain disorders a step closer
A team of researchers working at the MR-Center of the University Children's Hospital in Zürich has completed a pilot study using transcranial MR-guided focused ultrasound to treat 10 patients with neuropathic pain.
Barr to market generic LAMISIL tablets
Barr Pharmaceuticals has announced that Gedeon Richter, Plc. has received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a generic version of Novartis Pharmaceutical Corporation's LAMISIL (terbinafine hydrochloride) Tablets, 250 mg. The approval follows the expiration of pediatric exclusivity for LAMISIL.
New technology can rapidly disrupt existing biofilms that account for chronic diseases
Chronic and recurrent bacterial diseases are treatment-resistant due to the ability of the pathogens to establish biofilms, which act as fortresses built of extracellular DNA and proteins to protect populations of the bacteria.
FDA approves device that uses magnetic resonance image guided focused ultrasound to target and destroy uterine fibroids
The U.S. Food and Drug Administration (FDA) today approved the ExAblate 2000 System, a new medical device that uses magnetic resonance image guided focused ultrasound to target and destroy uterine fibroids, non-cancerous masses located in the uterus.
› Verified 3 days ago
Physical Therapists
Optometrists
Chiropractors
Speech-Language Pathologists
Podiatrists